Literature DB >> 21802164

Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.

Nilesh J Bokil1, Makrina Totsika, Alison J Carey, Katryn J Stacey, Viktoria Hancock, Bernadette M Saunders, Timothy Ravasi, Glen C Ulett, Mark A Schembri, Matthew J Sweet.   

Abstract

Uropathogenic E. coli (UPEC) are the primary cause of urinary tract infections. Recent studies have demonstrated that UPEC can invade and replicate within epithelial cells, suggesting that this bacterial pathogen may occupy an intracellular niche within the host. Given that many intracellular pathogens target macrophages, we assessed the interactions between UPEC and macrophages. Colonization of the mouse bladder by UPEC strain CFT073 resulted in increased expression of myeloid-restricted genes, consistent with the recruitment of inflammatory macrophages to the site of infection. In in vitro assays, CFT073 was able to survive within primary mouse bone marrow-derived macrophages (BMM) up to 24h post-infection. Three additional well-characterized clinical UPEC isolates associated with distinct UTI symptomatologies displayed variable long-term survival within BMM. UPEC strains UTI89 and VR50, originally isolated from patients with cystitis and asymptomatic bacteriuria respectively, showed elevated bacterial loads in BMM at 24h post-infection as compared to CFT073 and the asymptomatic bacteriuria strain 83972. These differences did not correlate with differential effects on macrophage survival or initial uptake of bacteria. E. coli UTI89 localized to a Lamp1(+) vesicular compartment within BMM. In contrast to survival within mouse BMM, intracellular bacterial loads of VR50 were low in both human monocyte-derived macrophages (HMDM) and in human T24 bladder epithelial cells. Collectively, these data suggest that some UPEC isolates may subvert macrophage anti-microbial pathways, and that host species differences may impact on intracellular UPEC survival.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21802164     DOI: 10.1016/j.imbio.2011.05.011

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  31 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

Review 2.  Invasion of Host Cells and Tissues by Uropathogenic Bacteria.

Authors:  Adam J Lewis; Amanda C Richards; Matthew A Mulvey
Journal:  Microbiol Spectr       Date:  2016-12

3.  Molecular characterization of the EhaG and UpaG trimeric autotransporter proteins from pathogenic Escherichia coli.

Authors:  Makrina Totsika; Timothy J Wells; Christophe Beloin; Jaione Valle; Luke P Allsopp; Nathan P King; Jean-Marc Ghigo; Mark A Schembri
Journal:  Appl Environ Microbiol       Date:  2012-01-27       Impact factor: 4.792

4.  Molecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisition.

Authors:  Scott A Beatson; Nouri L Ben Zakour; Makrina Totsika; Brian M Forde; Rebecca E Watts; Amanda N Mabbett; Jan M Szubert; Sohinee Sarkar; Minh-Duy Phan; Kate M Peters; Nicola K Petty; Nabil-Fareed Alikhan; Mitchell J Sullivan; Jayde A Gawthorne; Mitchell Stanton-Cook; Nguyen Thi Khanh Nhu; Teik Min Chong; Wai-Fong Yin; Kok-Gan Chan; Viktoria Hancock; David W Ussery; Glen C Ulett; Mark A Schembri
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

5.  Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.

Authors:  Marta Putrinš; Karin Kogermann; Eliisa Lukk; Markus Lippus; Vallo Varik; Tanel Tenson
Journal:  Infect Immun       Date:  2015-01-05       Impact factor: 3.441

6.  Strain- and host species-specific inflammasome activation, IL-1β release, and cell death in macrophages infected with uropathogenic Escherichia coli.

Authors:  K Schaale; K M Peters; A M Murthy; A K Fritzsche; M-D Phan; M Totsika; A A B Robertson; K B Nichols; M A Cooper; K J Stacey; G C Ulett; K Schroder; M A Schembri; M J Sweet
Journal:  Mucosal Immunol       Date:  2015-05-20       Impact factor: 7.313

7.  Histone Deacetylase Inhibitors Promote Mitochondrial Reactive Oxygen Species Production and Bacterial Clearance by Human Macrophages.

Authors:  Juliana K Ariffin; Kaustav das Gupta; Ronan Kapetanovic; Abishek Iyer; Robert C Reid; David P Fairlie; Matthew J Sweet
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

8.  Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.

Authors:  Kanna Nagamatsu; Thomas J Hannan; Randi L Guest; Maria Kostakioti; Maria Hadjifrangiskou; Jana Binkley; Karen Dodson; Tracy L Raivio; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-09       Impact factor: 11.205

9.  CRIg-expressing peritoneal macrophages are associated with disease severity in patients with cirrhosis and ascites.

Authors:  Katharine M Irvine; Xuan Banh; Victoria L Gadd; Kyle K Wojcik; Juliana K Ariffin; Sara Jose; Samuel Lukowski; Gregory J Baillie; Matthew J Sweet; Elizabeth E Powell
Journal:  JCI Insight       Date:  2016-06-02

10.  Intracellular Macrophage Infections with E. coli under Nitrosative Stress.

Authors:  Stacey L Bateman; Patrick Seed
Journal:  Bio Protoc       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.